Published in Br J Cancer on January 01, 1996
Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Cancer (1997) 0.93
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells. Nucleic Acids Res (2007) 0.84
Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Telomeres shorten during ageing of human fibroblasts. Nature (1990) 23.97
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Structure and function of telomeres. Nature (1991) 14.82
Telomere reduction in human colorectal carcinoma and with ageing. Nature (1990) 11.24
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A (1992) 10.19
The RNA component of human telomerase. Science (1995) 9.86
Origin of concatemeric T7 DNA. Nat New Biol (1972) 9.08
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell (1989) 8.68
An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell (1993) 6.89
Structure and function of telomeres. Annu Rev Genet (1989) 6.28
A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep (1980) 4.66
Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A (1994) 4.57
Cooperation between oncogenes. Cell (1991) 3.88
Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A (1994) 3.86
Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med (1995) 3.74
Transposons in place of telomeric repeats at a Drosophila telomere. Cell (1993) 3.54
The saccharomyces PIF1 DNA helicase inhibits telomere elongation and de novo telomere formation. Cell (1994) 3.52
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res (1989) 3.35
Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell (1995) 3.23
Apoptosis induced by anticancer drugs. Cancer Metastasis Rev (1992) 3.07
Tumor suppressor genes: the puzzle and the promise. Science (1989) 2.84
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature (1983) 2.77
Addition of telomere-associated HeT DNA sequences "heals" broken chromosome ends in Drosophila. Cell (1990) 2.59
Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol (1994) 2.57
Dynamics of telomere length variation in Tetrahymena thermophila. Cell (1987) 2.56
Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol (1994) 2.26
Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer (1993) 2.20
Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature (1990) 2.14
Activation of telomerase in a human tumor. Proc Natl Acad Sci U S A (1994) 2.11
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res (1993) 2.04
Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am J Hum Genet (1976) 1.82
Telomeres, telomerase and senescence. Bioessays (1990) 1.70
Telomerase activity in germline and embryonic cells of Xenopus. EMBO J (1994) 1.66
DNA damage and repair in telomeres: relation to aging. Proc Natl Acad Sci U S A (1995) 1.56
Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature (1982) 1.26
Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene (1994) 1.19
Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst (1990) 1.17
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog (1995) 1.04
Immortalization of a human colorectal adenoma cell line by continuous in vitro passage: possible involvement of chromosome 1 in tumour progression. Int J Cancer (1988) 0.99
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer (1990) 0.96
Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog (1995) 0.87
Telomeres draw a crowd at Toronto cancer meeting. Science (1995) 0.79
Telomerase: immortality enzyme or oncogene? Nat Genet (1995) 0.78
Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene (1999) 2.00
Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. J Natl Cancer Inst (1999) 1.73
Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol (1999) 1.57
Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene (1997) 1.33
The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell (2000) 1.26
Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene (1996) 1.17
Extracellular matrix components produced by SV40-transformed human epidermal keratinocytes. Int J Cancer (1984) 1.17
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene (1998) 1.16
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene (1999) 1.16
Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer (1993) 1.15
Growth requirements of human cervical epithelial cells in culture. Int J Cancer (1979) 1.10
Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumour promotion by phorbol esters and by deep skin wounding. Br J Cancer (1985) 1.06
Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res (1999) 1.05
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinog (1995) 1.04
Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells. J Cell Physiol (1987) 1.02
Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene (1997) 1.02
Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer (2001) 1.01
Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. J Pathol (2001) 0.95
Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres. Oncogene (2001) 0.95
Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Cell Growth Differ (1996) 0.95
The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes. Carcinogenesis (1982) 0.90
Differential effects of complete and second-stage tumour promoters in normal but not transformed human and mouse keratinocytes. Carcinogenesis (1984) 0.89
E-cadherin at the cell periphery is a determinant of keratinocyte differentiation in vitro. Biochem Biophys Res Commun (2000) 0.87
Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis. J Oral Pathol Med (2008) 0.87
Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res (1994) 0.86
Benzo(a)pyrene metabolism and DNA adduct formation in serially cultivated strains of human epidermal keratinocytes. Int J Cancer (1980) 0.86
Telomere-dependent senescence. Nat Biotechnol (1999) 0.86
Glycoproteins and glycosaminoglycans of cultured normal human epidermal keratinocytes. J Cell Sci (1983) 0.86
Migration and mitosis in the epidermis. Br J Dermatol (1984) 0.85
Non-promoting hyperplasiogenic agents do not mimic the effects of phorbol, 12-myristate, 13-acetate on terminal differentiation of normal and transformed human keratinocytes. Carcinogenesis (1984) 0.83
Phospholipase C mimics the differential effects of phorbol-12-myristate-13-acetate on the colony formation and cornification of cultured normal and transformed human keratinocytes. Carcinogenesis (1987) 0.83
Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Br J Cancer (1996) 0.82
Alteration of the extracellular matrix of cultured human keratinocytes by transformation and during differentiation. Int J Cancer (1985) 0.81
Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics (1997) 0.81
The radiosensitivity of cultured human and mouse keratinocytes. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.81
Tissue culture of human cholesteatomatous keratinocytes. Clin Otolaryngol Allied Sci (1983) 0.80
Genetic and functional analyses exclude mortality factor 4 (MORF4) as a keratinocyte senescence gene. Cancer Res (1999) 0.80
Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 (TIMPs -1 and -2) in fibroblasts are early indicators of oral sub-mucous fibrosis and ageing. J Oral Pathol Med (2012) 0.79
Association of increased telomere lengths in limited scleroderma, with a lack of age-related telomere erosion. Ann Rheum Dis (2008) 0.79
Elevated levels of the p53 tumour suppressor protein in the basal layer of recurrent laryngeal papillomas. Clin Otolaryngol Allied Sci (1993) 0.78
Sensitivity of normal and transformed rat liver epithelial cells to benzo[a]pyrene toxicity. Carcinogenesis (1981) 0.78
The p53 status of cultured human premalignant oral keratinocytes. Br J Cancer (1994) 0.78
Assignment of two human epidermal squamous cell carcinomas cell lines to more than one complementation group for the immortal phenotype. Mol Carcinog (1994) 0.78
Benzoyl peroxide interferes with metabolic co-operation between cultured human epidermal keratinocytes. Carcinogenesis (1984) 0.77
Responses of human cervical keratinocytes in vitro to tumour promoters and diethylstilboestrol. Carcinogenesis (1985) 0.77
Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. Eur J Cancer B Oral Oncol (1994) 0.76
The ultrastructure of whole cells from two human keratinocyte strains during cell spreading and island formation in vitro. Exp Cell Res (1981) 0.75
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15. Oncogene (2003) 0.75
Tissue culture of migratory skin of the external ear and cholesteatoma: a new research tool. J Otolaryngol (1984) 0.75
Supernatants from cultured human epidermal keratinocytes stimulate angiogenesis. Br J Dermatol (1984) 0.75
In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes. Oncogene (1989) 0.75
Early genetic and functional events in the pathogenesis of oral cancer. Radiat Oncol Investig (1997) 0.75
The effect of donor age on the proliferative response of human and mouse keratinocytes to phorbol, 12-myristate, 13-acetate. Carcinogenesis (1987) 0.75
Fibronectin production by cultured keratinocytes. J Invest Dermatol (1985) 0.75
Non-reciprocal contact inhibition of locomotion of chick embryonic choroid fibroblasts by pigmented retina epithelial cells. J Cell Sci (1978) 0.75